[Experimental prostaglandin E2 therapy of acute kidney failure due to the crush syndrome].
It has been shown for the first time that intraaortal injection of PGE2 to dogs with acute renal failure caused by the crush syndrome makes renal function (glomerular filtration, tubular reabsorption, renal plasmaflow, maximal tubular secretion, minute and diurnal diuresis) return to normal.
D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D000818:Animals; D003444:Crush Syndrome / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D015232:Dinoprostone; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D011458:Prostaglandins E / Q000627:therapeutic use*; D012774:Shock, Traumatic / Q000150:complications*; D013997:Time Factors
D011458:Prostaglandins E; D015232:Dinoprostone
Eksperimental'naia terapiia prostaglandinom E2 ostroĭ pochechnoĭ nedostatochnosti, vyzvannoĭ krash-sindromom.